Search clinical trials for: ChAdOx1-S [recombinant]

Total 4578 results

Fundação de Medicina Tropical Dr. Heitor Vieira...
Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM); XP Investimentos and other collaborators

Active, not recruiting

Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity (COVACManaus2)

Healthy | Comorbidities and Coexisting Conditions

Brazil
Universiteit Antwerpen

Completed

Immunogenicity After COVID-19 Vaccines in Adapted Schedules (IMCOVAS)

COVID-19 | Coronavirus Disease 2019

Belgium
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
Laboratorio Avi-Mex, S.A. de C.V.
National Council of Science and Technology, Mexico; Instituto Nacional de Enfermedades...

Completed

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

SARS-CoV-2 Infection

Mexico
D'Or Institute for Research and Education
Bill and Melinda Gates Foundation; Instituto Fernandes Figueira

Not yet recruiting

Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19) (TP-SCB-2019001)

Covid19

Brazil
AstraZeneca

Completed

Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study (REFORCO-B)

COVID-19

Brazil
Vaxxinity, Inc.
Syneos Health; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

COVID-19 Vaccines

Philippines, United States, Panama
François Spertini
University of Oxford

Completed

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) (TB039)

Tuberculosis | Mycobacterium Tuberculosis, Protection Against

Switzerland
SK Bioscience Co., Ltd.
GlaxoSmithKline; International Vaccine Institute; Coalition for Epidemic Preparedness...

Completed

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

Covid19

Thailand, Korea, Republic of, New Zealand, Philippines, Ukraine, Vietnam
University of Oxford

Completed

A Study of a New Vaccine Against Two Types of Ebola

Ebola

United Kingdom
Vaccitech (UK) Limited

Completed

First in Human Study of ChAdOx1-HBV

Healthy | Hepatitis B

United Kingdom
University of Oxford

Terminated

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

MERS (Middle East Respiratory Syndrome)

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)

Chikungunya Fever

United Kingdom
Vaccitech (UK) Limited

Recruiting

Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer

Prostate Cancer

United States
University of Calgary
Ortho Biotech, Inc.; Calgary Health Region

Completed

The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)

Brain Injury | Cardiac Surgery

Canada
University of Oxford

Active, not recruiting

Investigating a Vaccine Against COVID-19

Coronavirus

United Kingdom
University of Oxford

Completed

A Study of Intranasal ChAdOx1 nCOV-19

Coronavirus

United Kingdom
University of Oxford
University of Birmingham

Completed

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Tuberculosis

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)

Zika

United Kingdom
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz; Escola Nacional de Saúde Pública Sérgio Arouca... and other collaborators

Recruiting

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

SARS-CoV-2

Brazil
R-Pharm
AstraZeneca

Completed

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

COVID-19

United Arab Emirates
University of Oxford

Active, not recruiting

A Study of a Candidate COVID-19 Vaccine (COV001)

Coronavirus

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially

Healthy

United Kingdom
University of Oxford

Completed

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Rift Valley Fever

United Kingdom
University of Oxford

Active, not recruiting

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Ebola

Tanzania
King Abdullah International Medical Research Center
University of Oxford

Completed

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Middle East Respiratory Syndrome Coronavirus

Saudi Arabia
University of Oxford
MRC/UVRI and LSHTM Uganda Research Unit

Completed

A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults

Rift Valley Fever | RVF

Uganda
University of Oxford

Completed

A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1

Influenza

United Kingdom
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz

Recruiting

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

SARS-CoV-2 Infection

Brazil
Assiut University

Active, not recruiting

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

ChAdOx1 nCoV-19 Vaccine

Egypt
Shanghai Henlius Biotech
Hengenix Biotech Inc; Sanyou Biopharmaceuticals(Shanghai)Co., Ltd; Shanghai ZJ...

Withdrawn

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

COVID-19
University of Oxford
Bill and Melinda Gates Foundation; Medical Research Council, South Africa; University... and other collaborators

Unknown

COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Coronavirus

South Africa
Korea University Guro Hospital
Ajou University School of Medicine; Korean Center for Disease Control and Prevention and other collaborators

Recruiting

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Inflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 Vaccination

Korea, Republic of
Canadian Immunization Research Network
Massachusetts General Hospital; CHU de Quebec-Universite Laval; McGill University... and other collaborators

Active, not recruiting

Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity (MOSAIC)

COVID-19

Canada
Makerere University
MRC/UVRI and LSHTM Uganda Research Unit; Ministry of Health, Uganda; Epicentre; Makerere University Lung Institute and other collaborators

Not yet recruiting

Solidarity/Tokomeza Ebola Trial (TOKOMEZA)

Sudan Ebola Virus Vaccines
Barinthus Biotherapeutics

Completed

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

HPV Infection | CIN1

Belgium, United Kingdom, Estonia
University of Oxford

Completed

A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1

Seasonal Influenza

United Kingdom
R-Pharm
AstraZeneca; Russian Direct Investment Fund; The Gamaleya National Center of...

Completed

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

COVID-19

Azerbaijan
Baxalta now part of Shire

Completed

Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A

Hemophilia A

Germany
EuBiologics Co.,Ltd

Recruiting

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

COVID-19

Congo, The Democratic Republic of the
EuBiologics Co.,Ltd

Active, not recruiting

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

COVID-19

Philippines
National Institute of Allergy and Infectious Diseases...
Gilead Sciences; University of Oxford

Recruiting

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

HIV-1-infection

United States, Brazil
Hospital Moinhos de Vento
Pfizer; Universidade Federal do Paraná; Inova Medical

Completed

A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil

Covid19

Brazil
University of Oxford

Completed

A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

HIV

United Kingdom
Medical University of Vienna

Active, not recruiting

Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients (BOOST_TX)

COVID-19

Austria
FibroGen

Completed

A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Chemotherapy Induced Anemia

China
China Medical University Hospital

Unknown

Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

Retinopathy of Prematurity | Intraventricular Hemorrhage | Infant, Premature | Leukomalacia, Periventricular

Taiwan
Murdoch Childrens Research Institute
Indonesia University; Universitas Padjadjaran; Health Development Policy Agency... and other collaborators

Withdrawn

Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)

COVID-19

Indonesia
Umeå University

Not yet recruiting

Risk of COVID-19 Infection After Vaccination

Covid19 | Vaccination; Infection
University of Oxford
Ifakara Health Institute

Active, not recruiting

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Rabies

Tanzania

Search clinical trials for: ChAdOx1-S [recombinant]

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations